Literature DB >> 12040265

Utility of Y-STR haplotype and mtDNA sequence in personal identification of human remains.

Hiroyoshi Koyama1, Mineo Iwasa, Tsukasa Tsuchimochi, Yoshitaka Maeno, Ichiro Isobe, Tomohiro Matsumoto, Masataka Nagao.   

Abstract

The utility of Y-STR haplotype and mtDNA sequence in personal identification from human remains is demonstrated. In five cases, severely damaged human remains were identified by Y-chromosomal short tandem repeat (STR) (Y-STR) haplotyping and mitochondrial DNA (mtDNA) sequencing. DNA was extracted from highly adipoceratous tissues using the phenol-chloroform method and polymerase chain reaction amplified for Y-STR haplotyping and sequencing of two hypervariable regions, HV1 and HV2, of the mtDNA. The authors also profiled the Y-STR haplotype and mtDNA sequence of a blood sample that was obtained from the presumptive brother of the decedent. Y-STR haplotyping and mtDNA sequencing results were compared with one another and with the Anderson sequence. It was concluded from these data that the lower part of the body (Case 1), the human head (Case 2), the upper part of the body (Case 3), and the right arm (Case 4) were from the same individual, whereas another lower part of a body (Case 5) was from a relative of the presumptive brother. A novel descriptive way of a statistical characteristic, gene or haplotype diversity, is shown.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12040265     DOI: 10.1097/00000433-200206000-00014

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  2 in total

1.  Single nucleotide polymorphism profiling assay to confirm the identity of human tissues.

Authors:  Ronald Huijsmans; Jan Damen; Hans van der Linden; Mirjam Hermans
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

2.  Molecular exploration of the first-century Tomb of the Shroud in Akeldama, Jerusalem.

Authors:  Carney D Matheson; Kim K Vernon; Arlene Lahti; Renee Fratpietro; Mark Spigelman; Shimon Gibson; Charles L Greenblatt; Helen D Donoghue; Boaz Zissu
Journal:  PLoS One       Date:  2009-12-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.